尚未探索的纽带:线粒体衍生微蛋白和帕金森病
Kashish Patel1, Ritu Soni1, Jigna Shah1
1Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat 382481, India.
Pathology, research and practice
|July 22, 2025
概括
线粒体衍生 (MDPs) 显示出作为帕金森病 (PD) 新型治疗剂的前景. 对MDPs的研究为PD病原和潜在的疾病修饰治疗提供了新的见解.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 是一种流行的神经退行性疾病,其特征是多巴胺能神经元损失.
- 它的发病包括复杂的因素,包括线粒体功能障碍,氧化应激和神经炎症.
- 目前PD的治疗方法在很大程度上是症状性的,这凸显了对疾病修饰治疗的需要.
研究的目的:
- 审查线粒体衍生 (MDPs) 在帕金森病病原发生中的作用.
- 突出MDPs作为PD新药的治疗潜力.
- 探索新的线粒体信号通路,以迫切需要的治疗方向.
主要方法:
- 文献综述专注于PD中的线粒体功能障碍.
- 对线粒体衍生 (MDPs) 的研究分析,包括Humanin,SHLPs和MOTS-c.
- 检查MDPs对与PD相关的细胞应激反应的影响.
主要成果:
- 像Humanin,SHLPs和MOTS-c这样的MDP正在成为细胞应激的关键调节剂.
- 这些体在治疗炎症,氧化应激和PD中的代谢功能障碍方面展示了治疗机会.
- MDPs为开发下一代帕金森病治疗方法提供了一个有前途的途径.
结论:
- 线粒体功能障碍是PD病变的关键组成部分.
- MDPs代表了一类新的治疗点,有可能改变PD进展.
- 对MDP的进一步研究对于开发有效的疾病修饰疗法来应对日益增长的PD负担至关重要.
更多相关视频
09:29Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
Published on: May 4, 2016
7.3K
06:57Author Spotlight: Fluorescence-Based Quantification of Mitochondrial Membrane Potential and Superoxide Levels Using Live Imaging in HeLa Cells
Published on: May 12, 2023
8.3K
相关概念视频
Translocation of Proteins into the Mitochondria
3.3K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.3K
Parkinson's Disease: Overview
713
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
713
Mitochondrial Precursor Proteins
2.6K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
Most of the mitochondrial...
2.6K
Parkinson's Disease: Treatment
381
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
381
Mitochondrial Protein Sorting
4.4K
Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death. Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
4.4K
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
